Platelet transfusions to HLA-immunized recipients: how to be or not to be matched

被引：0
|
作者：
Rubinstein, Pablo [1 ]
机构：
[1] New York Blood Ctr, New York, NY 10021 USA
来源：
TRANSFUSION | 2010年 / 50卷 / 11期
关键词：
MOLECULARLY BASED ALGORITHM; HIGHLY SENSITIZED PATIENTS; ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS; HISTOCOMPATIBILITY DETERMINATION; REFRACTORY PATIENTS; HLAMATCHMAKER; ANTIGENS; DONORS; CELL; SEQUENCE;
D O I：
10.1111/j.1537-2995.2010.02850.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2292 / 2294
页数：3
相关论文
共 50 条
  • [41] ROLE OF HLA COMPATIBILITY IN PLATELET TRANSFUSIONS FROM UNRELATED DONORS
    HESTER, JP
    MCCREDIE, KB
    ROSSEN, R
    LICHTIGER, B
    FREIREICH, EJ
    JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (06): : A32 - A33
  • [42] A REEVALUATION OF CROSSMATCHING AND HLA MATCHING FOR PLATELET TRANSFUSIONS TO REFRACTORY PATIENTS
    HEAL, J
    BLUMBERG, N
    MASEL, D
    TRANSFUSION, 1985, 25 (05) : 460 - 460
  • [43] Randomised, Non-inferiority Trial of HLA Epitope Matched Platelet Transfusions for Alloimmunised Patients with Myeloid Bone Marrow Disorders
    Marsh, J.
    Pankhurst, L.
    Kallon, D.
    Brown, C.
    Gilbertson, A.
    Pigden, C.
    Deary, A. J.
    Mora, A.
    Brown, J.
    Liang, E.
    Choo, C. J.
    Hodge, R. L.
    Llwewlyn, C.
    Harding, K.
    Sage, D.
    Mijovic, A.
    Mufti, G. J.
    Stanworth, S. J.
    Navarrate, C. V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 33 - 33
  • [44] A PROSPECTIVE RANDOMIZED TRIAL OF HLA-MATCHED VERSUS MISMATCHED SINGLE-DONOR PLATELET TRANSFUSIONS IN CANCER-PATIENTS
    MESSERSCHMIDT, GL
    MAKUCH, R
    APPELBAUM, F
    UNGERLEIDER, RS
    ABRAMS, R
    ODONNELL, J
    HOLOHAN, TV
    FONTANA, J
    WRIGHT, D
    ANAGNOU, NP
    SHAN, TC
    CHESBRO, B
    DEISSEROTH, AB
    CANCER, 1988, 62 (04) : 795 - 801
  • [45] Can HLA matched recipients receive less immunosuppression?
    Takemoto, Steven K.
    Pinsky, Brett
    Salvalaggio, Paolo R.
    Lentine, Krista
    Burroughs, Thornas E.
    Willoughby, Lisa
    Schnitzler, Mark A.
    Graff, Ralph J.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 39 - 39
  • [46] Can HLA matched recipients receive less immunosuppression?
    Takemoto, Steven K.
    Pinsky, Brett
    Salvalaggio, Paolo
    Graff, Ralph
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 209 - 209
  • [47] Can HLA matched recipients receive less immunosuppression?
    Takemoto, Steven K.
    Pinsky, Brett
    Salvalaggio, Paolo R.
    Lentine, Krista
    Burroughs, Thomas E.
    Schnitzler, Mark A.
    Brennan, Daniel
    Graff, Ralph J.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S39 - S39
  • [48] Successful treatment of platelet transfusion refractoriness. The use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized leukaemia patients
    Kekomaki, S
    Volin, L
    Koistinen, P
    Koivunen, E
    Timonen, T
    Kekomaki, R
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS315 - PS315
  • [49] Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation (vol 60, pg 473, 2020)
    Seike, Keisuke
    Fujii, Nobuharu
    Asano, Naomi
    Ohkuma, Shigenori
    Hirata, Yasushi
    Fujii, Keiko
    Sando, Yasuhisa
    Nakamura, Makoto
    Naito, Kazunori
    Meguri, Yusuke
    Asada, Noboru
    Ennishi, Daisuke
    Nishimori, Hisakazu
    Matsuoka, Ken-ichi
    Tsubaki, Kazuo
    Otsuka, Fumio
    Maeda, Yoshinobu
    TRANSFUSION, 2020, 60 (11) : 2765 - 2765
  • [50] How should the safety and efficacy of platelet transfusions be assured?
    Williamson, LM
    BLOOD REVIEWS, 1998, 12 (04) : 203 - 214
12345